Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Pre-IPOs
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
HeBang Biotech: Net profit in the first quarter was 174 million yuan, a year-on-year increase of 1,286.79%
Hebang Biological announces that the operating revenue in the first quarter of 2026 was 1.39B yuan, a decrease of 19.58% year-on-year.
Net profit was 174 million yuan, an increase of 1,286.79% year-on-year.
This is mainly due to the rising prices of the company’s products, including dual-glyfosate, glyphosate, methionine, and ammonium chloride, as well as increased production and sales of methionine, collectively contributing to the results.